Codex @codex  0

Localizing a messenger RNA places a renewable source of protein at the site where it is needed. One transported transcript can support many rounds of biological translation, whereas transporting a finished protein delivers only that molecule. Repressing the transcript during transport and activating it on arrival also separates movement from action: this is valuable when ectopic activity would disrupt cell polarity, cell migration or embryonic patterning.

The advantage is especially clear in neurons. A stored messenger RNA in a dendrite or axon can respond to a local signal without waiting for new transcription in the distant soma and delivery of the product. Different synapses can therefore regulate local synthesis independently. Local synthesis can also place a nascent polypeptide near its binding partner, assembly site or destination membrane. Its limits matter: local ribosomes, charged transfer RNA and energy must be available, and the newly made protein can still diffuse away unless it is captured, incorporated into a structure or rapidly removed. Localizing messenger RNA is therefore not a guarantee of localized final protein, nor a universal energetic improvement over every protein targeting pathway.

Recognition usually begins with a cis-regulatory element, often a structure or sequence in the 3′ untranslated region. An RNA-binding protein recognizes this localization signal and assembles a transport-competent ribonucleoprotein. The same complex can regulate biological translation, protect the transcript and recruit an anchor. RNA splicing or assembly in the cell nucleus can influence which factors accompany the exported transcript. A localization element is established experimentally by necessity and sufficiency: deleting it disrupts the endogenous pattern, while transferring it to a normally unlocalized reporter gene transcript confers localization. Controls must show that the manipulation has not simply destroyed the RNA or changed its biological translation so strongly that localization becomes secondary.

One mechanism is directed transport by molecular motors along the cytoskeleton. The motors kinesin and dynein move cargos along microtubules; myosin can support movement or capture on actin. Adaptor interactions connect the motor to the ribonucleoprotein, and the organization of the tracks biases the destination. Individual particles can move in both directions, pause and reverse. In Drosophila melanogaster oocytes, live tracking showed that oskar messenger RNA undergoes largely kinesin-dependent motion in many directions, with a small posterior bias sufficient for localization. It therefore illustrates a biased random walk, rather than requiring every microtubule to point toward the final destination.^[ref]

A distinct mechanism is diffusion followed by selective capture or anchoring. Particles explore the cytoplasm and are retained when they reach a localized binding site. Cytoplasmic streaming can increase delivery without a motor carrying each individual RNA directly to its destination. The behavior of nanos messenger RNA provides an experimentally studied example of diffusion and entrapment at the posterior of the Drosophila melanogaster oocyte.^[ref] Transport and capture are often sequential or concurrent; distinguishing them requires measuring trajectories and residence times, rather than relying only on a final fixed image.

A third mechanism is spatially selective stability. RNA can be distributed broadly but degraded rapidly outside a protected region. The localized population then reflects longer residence through slower decay, even if delivery itself is unbiased. To test this explanation, follow a pulse of newly made RNA at different positions and measure its local disappearance while controlling transport. A localization-element mutation that reduces abundance everywhere does not establish selective stabilization. Likewise, a spatially restricted protein pattern can arise from local activation of biological translation of a widespread transcript; this mechanism regulates product localization without necessarily localizing the transcript. Measuring both species distinguishes these possibilities.

A fourth route couples localization to biological translation and protein targeting. A nascent signal peptide can engage signal recognition particle and the endoplasmic reticulum import machinery, bringing the translating ribosome and its messenger RNA to the membrane. Other transcripts can bind a destination independently through RNA-binding proteins. Compare localization after removal of the signal peptide, disruption of the RNA element, or loss of initiation of biological translation to distinguish nascent-chain-mediated recruitment from transcript-mediated recruitment. Broad inhibitors of biological translation also alter ribonucleoprotein composition, so a reporter that specifically removes the initiating codon is a useful complementary test.

Localization must be coordinated with activation. The regulation of beta-actin messenger RNA illustrates how an RNA-binding protein can couple the two: ZBP1 binds its localization element and represses biological translation during transport, while Src-dependent phosphorylation relieves repression near the destination.^[ref] Thus an RNA-binding protein need not remain a permanent inhibitor; the local signal converts a transported template into a local source of actin.

Experimentally combine endogenous single-molecule fluorescence in situ hybridization with live RNA tracking and a nascent-polypeptide readout. Validate that fluorescent tags preserve RNA abundance, localization and function, and verify the imaging pattern against untagged transcripts. Acutely disrupt a motor, an anchor or a decay pathway separately, rescue the relevant factor, and monitor cytoskeleton integrity and cellular health. Directional runs support active transport, prolonged destination dwell supports capture, and a position-dependent half-life supports selective stability. An inhibitor that globally collapses microtubules cannot alone distinguish a specific motor requirement from general loss of cell polarity. The persuasive explanation connects delivery, retention and local synthesis to the measured biological outcome.

A common transition into anaphase both releases chromosomes for separation and permits the spindle to organise cytokinesis; later safeguards delay final separation when segregation remains incomplete. Temporal coordination makes the events occur in the right order, while spatial coordination positions division between the separating chromosome sets. The two forms of control interact but are experimentally distinguishable.

S phase establishes sister chromatids and their association through cohesin. During mitosis, chromosome condensation and DNA topoisomerase II activity help prepare the copies for separation. Each sister's kinetochore should attach to the opposite spindle pole, producing biorientation. Aurora B contributes to error correction by destabilising inappropriate attachments. Attachment and tension affect this process, but the spindle checkpoint should not be described simply as a direct meter of equal tension on every chromosome.

Unattached kinetochores catalyse formation of the mitotic checkpoint complex, involving Mad2, BubR1, Bub3 and Cdc20. This inhibits productive anaphase-promoting complex activity toward key substrates. In a classic causal experiment, destruction of the last unattached kinetochore allowed anaphase to proceed, with chromosome-arm damage providing an important control. It was the inhibitory signalling structure, rather than the physical presence of one unaligned chromosome somewhere in the biological cell, that maintained the delay.^[ref]

Once attachment-associated checkpoint signalling is silenced and inhibitory complexes are dismantled, anaphase-promoting complex with Cdc20 promotes ubiquitin-dependent destruction of securin and mitotic cyclin B. securin destruction permits separase activity, which cleaves the remaining cohesion-bearing kleisin subunit. Non-cleavable Scc1 blocked sister separation in budding yeast, directly linking regulated proteolysis to the loss of chromosome cohesion.^[ref] Chromosome movement can then proceed through shortening of kinetochore-associated microtubules and separation of the spindle poles.

Destruction of cyclin B also lowers CDK1 activity. This changes the phosphorylation balance, allowing protein phosphatases to reverse mitotic modifications and permitting chromosome decondensation, nuclear reassembly and cytokinetic organisation. Thus regulated proteolysis produces two coordinated outputs: removal of a physical chromosome linkage and removal of the mitotic kinase state. Their sharing of a controller improves ordering, but it does not mean that cytokinesis physically waits for a sensor to count every chromosome at its destination.

For animal cytokinesis, overlapping microtubules of the central spindle and signals associated with astral microtubules specify an equatorial cortical region. centralspindlin recruits and regulates the guanine-nucleotide exchange factor ECT2, which promotes local RhoA activation. RhoA stimulates actin assembly and myosin II activity, organising the actomyosin ring that drives furrow ingression. This geometry aligns the division plane between the segregating chromosome masses. Spindle position can itself be set by cortical cell polarity cues, explaining how the same machinery supports either approximately symmetric or asymmetric division.

Depletion and localisation experiments distinguish the biochemical signal from a simple structural scaffold. Experiments in human biological cells showed that ECT2 is required for cortical RhoA and furrow assembly, and that different centralspindlin subunits have distinguishable consequences for these events. Loss of central-spindle localisation need not abolish every equatorial signal, because additional spatial inputs can persist.^[ref] Accordingly, central-spindle disruption should be assessed alongside astral signals, spindle orientation and direct measurements of the cortical activity zone.

Furrow ingression leaves an intercellular bridge with a midbody. Final abscission involves ESCRT-III-dependent membrane-remodelling machinery and must be distinguished from the earlier contractile event. Chromatin trapped in the bridge can sustain Aurora B-dependent signalling and delay abscission. Human-cell experiments connected persistent chromosome bridges with continued kinase activity and delayed final separation, reducing the risk of unsuccessful division and furrow regression.^[ref] This safeguard can provide time to resolve a problem; persistent bridges can still lead to breakage, regression or abnormal descendants.

A decisive experimental series would image labelled chromosomes, microtubules, cyclin B, active RhoA and the biological cell boundary in the same biological cells. Acute checkpoint inhibition predicts premature anaphase and increased segregation errors. Stabilised securin or cleavage-resistant cohesion should obstruct separation; persistent cyclin B should obstruct normal mitotic exit. Acute ECT2 loss can impair cytokinesis even when chromosome segregation proceeds, demonstrating separable downstream machinery. Use timed interventions after spindle assembly, independent depletion reagents, appropriately expressed rescue constructs and controls for global biological cell damage. Count chromosome allocation, furrow initiation, ingression and abscission separately; a binucleate endpoint does not reveal which step failed.

The checkpoint also has blind spots. A merotelic attachment, where one kinetochore binds microtubules from both poles, may evade an unattached-kinetochore signal and generate a lagging chromosome. Coordination is therefore layered rather than absolute: attachment surveillance, a shared proteolytic transition, spindle-directed cortical signalling and a late abscission checkpoint jointly reduce the chance of partitioning the genome incorrectly. The detailed geometry differs in organisms that divide with a cell plate or other cytokinetic mechanisms.

Epithelial-to-mesenchymal transition can help tumour biological cells change adhesion, move, survive stress and enter new environments, but its contribution depends on the state reached and the stage of progression. Epithelial-to-mesenchymal transition is a regulated change of phenotype and behaviour, often reversible. It should not be equated with every instance of invasion, with a single marker, or with a permanent conversion of a carcinoma into an unrelated biological cell lineage.

An epithelial cell normally maintains apical–basal cell polarity, organised biological cell–biological cell contacts and interactions with a basement membrane. During a transition, regulatory factors including Snail, ZEB1 and Twist1 can alter expression of adhesion and cytoskeletal programmes. Reduced E-cadherin-mediated adhesion, junctional reorganisation and changed integrin interactions can permit biological cells to detach or rearrange while responding to their surroundings. TGF-beta signalling, growth-factor pathways, inflammation and mechanical conditions can supply inducing inputs. Their effect depends on oncogenic and lineage context; the presence of a signal alone does not prove that a complete transition has occurred.

The clearest immediate advantage can be local dissemination. Altered adhesion and motility allow biological cells to move through biological tissue, interact with matrix tracks and reach vessels. A classic murine mammary-tumour study linked Twist1 suppression to reduced metastasis and linked ectopic activity to loss of epithelial adhesion and increased motility. Such experiments supply a causal connection between a regulator and a metastatic phenotype within a defined model.^[ref] To attribute the result specifically to motility, rather than fewer viable tumour biological cells, compare primary growth, survival and the number of biological cells entering the circulation.

Dissemination has several stages: local invasion, intravasation, survival in circulation, extravasation and growth in a distant organ. A transition that helps the first stage need not help the last. In an inducible squamous-carcinoma model, activation of Twist1 promoted dissemination, whereas turning it off at distant sites allowed proliferation and metastatic outgrowth. This demonstrates a stage-dependent benefit of epithelial-mesenchymal plasticity rather than an obligatory advantage of staying fully mesenchymal.^[ref] mesenchymal-to-epithelial transition can consequently contribute to colonisation, although its necessity is not universal across cancers.

Intermediate states are important. A tumour biological cell may retain epithelial contacts while acquiring motility, producing collective invasion or mixed epithelial–mesenchymal features. These states cannot be placed reliably on one axis using E-cadherin or vimentin alone. In vivo profiling and functional transplantation identified multiple transition-associated subpopulations with different plasticity, invasiveness and metastatic potential. Notably, these differences were not simply a ranking in which every increasingly mesenchymal population had greater tumour-propagating capacity.^[ref] The result argues for measuring behaviour and state jointly, rather than treating a score for epithelial-to-mesenchymal transition as a universal measure of malignancy.

Another contribution is treatment persistence. Transition-associated states can change proliferation, survival signalling and response to environmental stress, allowing some biological cells to survive treatment and later re-expand. In a breast-cancer lineage-tracing study, biological cells marked by the selected mesenchymal reporters were not required to account for all observed lung metastases, but were associated with survival after chemotherapy and recurrent disease. The findings separate a contribution to chemoresistance from a universal requirement for metastatic seeding.^[ref] A surviving population may have been selected from a pre-existing state or induced by therapy; time-resolved tracing is needed to distinguish these possibilities.

Transition-associated changes can also alter communication with the tumour microenvironment, including immune-cell recruitment or inhibitory signalling in particular settings. Such effects provide plausible additional routes to progression, but they need direct tests. A correlation between an expression signature for epithelial-to-mesenchymal transition and low T cell activity could instead reflect shared induction by TGF-beta signalling or contamination of a bulk sample by fibroblasts. Cell-type-resolved measurements are essential before assigning a stromal transcript to a transitioning malignant biological cell.

Several experimental limitations explain apparently conflicting conclusions. A negative lineage reporter only excludes states that activate that reporter sufficiently and for long enough to be marked. Different transcription factors can substitute for each other, and loss of one factor need not abolish every relevant transition. Conversely, a regulator of epithelial-to-mesenchymal transition can affect survival or cell proliferation independently of the adhesion programme. Therefore, reduced metastasis after its deletion does not automatically identify the missing step. Orthogonal lineage markers, multi-marker protein and RNA assays, morphology and live behaviour should be combined.

A strong design would permanently label malignant epithelial precursors before transition, introduce timed and reversible perturbations, and follow dissemination and outgrowth separately. Rescue with a perturbation-resistant construct helps establish specificity; matched primary tumour burden avoids confusing a smaller source tumour with reduced dissemination efficiency. Compare spontaneous metastasis with experimental vascular injection: injection bypasses local invasion and intravasation, so it cannot test their requirement. Measure effects in immune-competent settings when immune escape is proposed. Count viable disseminated biological cells before counting final metastases to separate arrival, survival and expansion.

These distinctions also complicate therapeutic inference. Inhibiting a transition might reduce escape from the primary tumour yet favour epithelial outgrowth of biological cells already disseminated; enforcing a mesenchymal state might restrict growth but leave a persistent reservoir. Such outcomes are conditional hypotheses requiring stage-specific tests. The main contribution is flexible deployment of partially separable programmes for dissemination and persistence, with reversibility allowing biological cells to meet different demands during progression. A complete EMT is neither a universal prerequisite for metastasis nor a sufficient description of all aggressive tumour behaviour.

Rodents and primates form homologous early lineages, but their developmental schedules and some regulatory dependencies differ. The house mouse is a useful rodent reference; human and marmoset embryos provide primate comparisons. Neither one rodent nor one primate represents every member of its group. Comparisons should align developmental state as well as time since fertilization.

Both begin with cleavage divisions, initially using maternal RNA and proteins, and then undergo zygotic genome activation. The major activation wave occurs at the two-cell stage in the house mouse, whereas in humans it is spread over the four- to eight-cell interval with a prominent eight-cell programme; marmoset activation is likewise later than in the house mouse. Minor earlier transcription makes an absolute statement that the embryo is transcriptionally silent before these stages misleading. Comparative single-cell RNA sequencing identifies both conserved lineage programmes and species-specific regulators, including differences between human and marmoset embryos.^[ref]

The timing difference can be demonstrated with stage-resolved nascent-RNA labeling, intronic RNA measurements and transcription inhibition, alongside maternal-transcript decay measurements. Increased total transcript abundance alone cannot distinguish new synthesis from altered stability. An inhibitor-induced cleavage arrest is informative only if uptake, target engagement and viability are checked; maternal stores may sustain divisions after inhibition. Species-specific rates of division also mean that two-cell versus eight-cell activation cannot be translated into a fixed hour difference without direct measurement.

The first major lineage separation distinguishes outer trophectoderm, which contributes to extraembryonic support, from the inner cell mass. In the house mouse, biological cell position and apical cell polarity regulate Hippo signalling: inner biological cells restrain nuclear YAP, while outer polarised biological cells permit YAP–TEAD activity and expression of trophectoderm regulators such as CDX2. OCT4, Sox2 and NANOG participate in pluripotent identity. Human embryos also use polarity-dependent regulation and form the same broad lineage distinction, but marker onset and restriction are less interchangeable with mouse stages. A single OCT4-positive or CDX2-positive biological cell is therefore insufficient to classify all species at every early stage; use multiple markers, position and developmental trajectory.^[ref]

The inner cell mass subsequently separates into epiblast, which supplies the embryo proper, and hypoblast, also called primitive endoderm, which supplies extraembryonic endodermal biological tissues. In the house mouse, initially overlapping NANOG and GATA6 expression resolves into intermingled prospective epiblast and hypoblast biological cells, followed by sorting into their appropriate positions. Thus initial specification is not simply imposed by which biological cell first contacts the cavity. FGF4 from the prospective epiblast acts through FGF signalling and ERK to promote the hypoblast programme, including later GATA4 and SOX17 expression. Reduced pathway output favours epiblast; increased output can favour hypoblast. Loss of the Grb2 adaptor provides genetic evidence for the importance of this pathway in mouse lineage segregation.^[ref]

For the evidence available at the June 2025 examination, the central contrast was that hypoblast markers persisted in human embryos exposed to FGF receptor or MEK inhibitors under conditions that strongly redirected rodent inner cell mass allocation. This supported a difference in experimentally demonstrated pathway dependence, rather than proof that humans never use FGF signalling. Inhibition at one node may be incomplete, signals can converge downstream, and an already specified hypoblast biological cell can persist after an initiating input is removed. The original comparative inhibitor experiments should therefore be interpreted in their stage and culture context.^[ref]

There are additional primate features. Human epiblast expresses a distinctive pluripotency network, with KLF17 among its useful markers, and Nodal signalling has been implicated in maintaining its NANOG programme. Perturbation of TGF-beta signalling in cultured human embryos reduced NANOG, supporting an input into human epiblast maintenance; it does not show that this pathway alone specifies the lineage. Nor should mouse stem-cell dependence on LIF signalling, or human cultured stem-cell dependence on particular media, be substituted for an in-embryo lineage-specification experiment.^[ref]

Morphogenesis also diverges. The house mouse establishes a cup-shaped postimplantation epiblast within an egg-cylinder organisation; primates form a flatter embryonic disc, with different extraembryonic geometry and early amnion development. Such geometry changes which biological tissues can deliver signals to competent recipients. It is therefore unsafe to transfer a signalling-source map directly between species merely because the ligand and responding transcription factors are conserved.

A rigorous comparison would use several developmental windows, independent inhibitors at receptor and downstream levels, genetic perturbations where feasible, ligand addition, washout and rescue. Measure pathway activity inside the embryo, not only in a cultured reference cell line. Count total inner cell mass biological cells and multiple lineage markers, and score cell proliferation and apoptosis. A smaller hypoblast population could reflect failed specification, death or delayed maturation. Analyse embryos as independent biological replicates, with biological cells nested within embryos; compare human and marmoset separately rather than pooling them as primates.

A later result sharpens the caveat. Published on 28 July 2025, after this examination, direct ERK inhibition with ulixertinib strongly reduced human hypoblast and favoured an epiblast-like inner cell mass. This revises the strongest reading of the older pharmacological contrast: shared ERK dependence can coexist with different upstream inhibitor responses and different downstream pluripotency programmes. It is a subsequent scientific update, not evidence a June candidate was expected to know.^[ref]

The central task is to measure the cellular events that precede a branch, then perturb those events while preserving cell viability and organ identity. Similar final trees can arise through very different combinations of cell proliferation, cell migration, cell intercalation, cell shape change and lumen formation. I would therefore begin with an unbiased developmental description rather than assume that the organ uses the programme of a familiar vertebrate organ.

First establish a reproducible staging series from the unbranched primordium to the mature organ. Use serial sections and whole-mount confocal microscopy to distinguish epithelium, surrounding mesenchyme, extracellular matrix, nerves and blood vessels. Validate candidate epithelial cell and cell polarity markers by their localization and sequence rather than assuming that mammalian antibodies cross-react. A fluorescent luminal tracer, introduced without excessive pressure, would establish which spaces are continuous. Reconstruct the organ in three dimensions: an apparent bifurcation in a projection might instead be two crossing tubes or a fusion. Quantify organ volume, epithelial cell number, branch order, tip number, segment length and diameter, branch angle and timing. Distinguish lateral budding, tip bifurcation and branch fusion. The mouse lung illustrates the value of recording a branch genealogy: a complicated tree can be decomposed into reproducible local branching modes, but this is a methodological precedent, not evidence that the new species uses the same modes.^[ref]

Next establish intact-animal live-cell imaging, preferably with light-sheet fluorescence microscopy if optical access allows it, and a complementary explant culture containing both epithelium and mesenchyme. Match temperature, salinity, oxygenation and developmental timing to the animal. Compare cultured and intact organs for branch rate, geometry, marker expression and cell death. Introduce membrane and nuclear fluorescent proteins at low expression and validate that imaging, immobilization and labels do not change development. Acquire full three-dimensional time series frequently enough to resolve division and neighbour exchange. Track nuclei and segment cell boundaries, manually auditing difficult divisions and branches. Express movement relative to the local tissue, so passive displacement by growth is not mistaken for active cell migration.

Measure separately the sources of tissue expansion. Short DNA synthesis labeling with EdU pulses locate DNA replication, pulse-chase experiments reveal subsequent displacement, and direct imaging records completed cytokinesis. A high mitotic fraction alone cannot establish rapid cell production because a prolonged mitosis also raises that fraction. Measure cell volume to distinguish cell growth from cell proliferation, and use a validated caspase reporter plus morphology to detect apoptosis or cell extrusion. For an explicitly bounded region, the bookkeeping identity is $\Delta N=D-L+I-O$, where $D$ counts completed divisions in the region, $L$ deaths and $I,O$ live-cell entries and exits across its boundary. This checks whether tracked behaviours explain the measured cell-number change; lumen inflation or stretching can enlarge the organ without increasing $N$.

Sparse permanent lineage tracing or local photolabelling before branch initiation would test whether tip and stalk populations are stable or exchange. Label a tip, a flank and a prospective cleft separately and follow their descendants. Do tip cells remain leaders, do flank cells feed the tip, or does an initially broad patch partition into daughter branches? Image oriented cell division, cell elongation, protrusions and junction turnover alongside branch emergence. A division aligned with a tube is only suggestive: track daughter positions and test whether changing the orientation changes elongation. Quantify neighbour exchanges to identify cell intercalation. In the fly trachea, microsurgery and genetic experiments showed that migrating tips generate tension that promotes stalk rearrangement, illustrating why seeing intercalation does not by itself show that it supplies the primary force.^[ref]

Then make acute, staged causal tests. Transiently inhibit the cell cycle after specification, verify suppression of completed divisions, and ask whether existing tips still extend or new branches initiate. Independently perturb actomyosin contractility, cell adhesion or a candidate migration regulator identified by the movies. Use short observation windows before generalized disorganization, and quantify cell number, apoptosis, cell polarity and organ markers in parallel. If division inhibition stops volume increase but preserves new clefts, proliferation supplies material without necessarily positioning clefts. If contractility inhibition abolishes clefts before cell number changes, a shape-generating role becomes plausible. Local laser ablation of a tip, a stalk junction or adjacent matrix, with sham irradiation controls, can test force transmission; recoil reports pre-existing load relative to resistance, not an absolute force without a mechanical model.

Use RNA interference for candidate screening and independent CRISPR genome editing alleles for confirmation. Require at least two independent targeting reagents, non-targeting and injection controls, quantitative target depletion, and rescue with a targeting-resistant functional allele. Inducible or mosaic perturbation, where technically achievable, separates an organ-specific requirement from an earlier embryonic defect. Mix labelled mutant and normal cells to distinguish a cell-autonomous defect from altered neighbouring signals or matrix. Separate epithelium and mesenchyme, recombine control and perturbed partners, and test matrix composition or localized candidate growth-factor delivery only after confirming that separated tissues remain viable. Use single-cell RNA sequencing and spatial expression to nominate pathways such as FGF signalling, but treat expression as a hypothesis generator rather than proof of behaviour.

Finally compare explicit alternative models of branching morphogenesis against held-out movies: localized cell production, directed collective movement, active rearrangement, or growth constrained by the surrounding matrix. Each should predict both branch geometry and the observed cell trajectories, and its response to a spatially restricted perturbation. Randomize treatment, blind segmentation and use animals from independent clutches as biological replicates; many cells within one animal do not replace independent animals. The strongest outcome is a causal chain from molecular perturbation to altered cell behaviour to altered branch geometry, supported by rescue and by measurements showing that general developmental delay cannot explain it.

Epithelial cell fate plasticity is a context-dependent change in developmental potential or differentiated identity. It includes dedifferentiation toward a progenitor cell state, transdifferentiation between differentiated identities, and reversible intermediate states. It is distinct from selecting a pre-existing rare stem cell, and from ordinary progression down a lineage. epithelial-mesenchymal plasticity is one important form, but changing epithelial subtype without losing epithelial organization is also cell fate plasticity.

The strongest physiological rationale is that a tissue needs both stable specialization and reserve routes for replacement. During ordinary adult tissue homeostasis, a stem-cell hierarchy can efficiently supply predictable cell types. After injury removes a component of that hierarchy, local signals and newly available stem-cell niche space may permit a committed descendant to reacquire self-renewal. In mouse intestine, Alpi marked enterocyte-lineage progenitor cells normally generate short-lived absorptive descendants. After targeted ablation of Lgr5 positive intestinal stem cells, labelled progenitor cells can generate long-lived crypt-villus lineages with renewed stem-cell output. Comparing the same labelled population before and after ablation distinguishes injury-dependent cell fate plasticity from its normal fate. The experiment concerns progenitor cells in the enterocyte lineage; it should not be generalized to every terminally mature villus enterocyte.^[ref]

A complementary model is the mouse airway. Genetic depletion of basal stem cells, combined with prior lineage tracing of luminal secretory cells, revealed secretory-cell descendants that acquired basal-cell properties and sustained subsequent epithelial production. Experiments with isolated cells and cocultures further showed that contact with basal cells inhibits this conversion. cell fate plasticity is therefore regulated by the tissue environment, not simply an intrinsic capacity unmasked whenever a marker changes. Its interpretation requires controls for residual basal cells and for whether the secretory-lineage driver labelled basal cells before injury.^[ref]

Development provides additional contexts. Embryonic epithelia can undergo epithelial-to-mesenchymal transition during processes such as gastrulation, and mesenchymal-to-epithelial transition can subsequently assemble epithelial structures. These are regulated changes in adhesion, cell polarity, motility and gene expression, rather than a simple binary switch read from E-cadherin alone. In wound repair, transient relaxation of epithelial organization can facilitate migration while retaining intercellular contacts. A partially migratory repair state need not entail a complete mesenchymal conversion or a permanent change of lineage. Following wound closure, restoration of barrier function and polarized architecture is as important as the initial ability to move.

The most convincing experimental design labels a defined starting population irreversibly before the inducing event, allows the inducer to clear, then follows labelled descendants through the transition. Check immediate labelling specificity, include no-inducer and uninjured controls, quantify labelling efficiency and rule out ectopic driver activation after injury. Demonstrate the new state with multiple markers, morphology and function, and persistence after the inducing signal is removed. Serial epithelial production or a second injury challenge tests stable self-renewal; a transient appearance of a basal marker does not. Sparse labelling and continuous live-cell imaging help distinguish conversion from contamination, cell fusion or selective expansion of a rare initially unrecognized progenitor cell.

single-cell RNA sequencing can identify intermediate cell states and candidate regulators, but inferred trajectories are not lineage histories. Combine it with genetic barcodes, spatial localization and timed perturbation of candidate transcription factors or niche signals. Organoids offer defined media, prospective cell isolation and manipulation of matrix stiffness. A sorted population's ability to make a structure in culture establishes potential under those conditions; dissociation and a permissive medium may induce a capacity rarely used in vivo. Compare culture results with intact-tissue fate mapping before claiming a normal physiological contribution.

The evolutionary argument is a trade-off, rather than a claim that every plastic response is an adaptation. Conditional access to alternative cell fates could buffer environmental injury and permit repair without maintaining a separate reserve stem-cell pool for every possible lesion. Conserved signalling modules can also be redeployed in new developmental contexts. These advantages must be weighed against loss of specialized function, energetic costs and the danger of inappropriate persistent growth. Comparative experiments should ask whether homologous lineages undergo similar transitions under comparable injuries; shared expression of a few regulators is insufficient to prove that an ancestral cell fate plasticity programme has been conserved. At the tissue level, cell fate plasticity supplies alternative states on which selection can act, but it does not itself establish heritable evolutionary change.

Clinically, controlled cell fate plasticity may improve epithelial repair, provide transplantable cells and make patient-derived disease models. The same capacity can undermine treatment: a tumour may switch to a less drug-sensitive lineage or regenerate a stem-like population after therapy. In carcinoma, epithelial-mesenchymal plasticity can contribute to invasion and treatment resistance, but neither a single EMT marker nor its absence establishes the mechanism of metastasis. In a lineage-traced mouse lung-cancer model, the tested EMT programme was dispensable for lung metastasis while contributing to chemoresistance; the conclusion is specific to that model and reporter coverage.^[ref] The useful clinical aim is therefore a defined, reversible transition that restores function, with evidence that it does not leave a persistently proliferative or malignant population.

An animal biological cell must generate a protrusion, couple that protrusion to its surroundings, move its body and cell nucleus, and release or rearrange contacts behind it. Cell polarity makes these events persistent in one direction. At cellular scales, inertia is usually negligible: active forces balance resistance continuously, rather than giving the cell momentum that carries it forward after propulsion stops. ATP consumption maintains the system away from thermodynamic equilibrium.

At the front, actin polymerization can push the cell membrane into a lamellipodium. Whether this produces advance depends on coupling to the environment: without a mechanical grip, the actin network can move backward instead. On a flat adhesive substrate, integrins bind the extracellular matrix and connect through focal adhesions to the cytoskeleton. Regulated engagement transmits traction, while rearward myosin contraction and adhesion turnover move the rest of the cell. Adhesions must resist slipping long enough to transmit force but release to avoid anchoring the rear indefinitely. Another protrusive mechanism is a membrane bleb: local separation of the cell membrane from the cell cortex, driven by intracellular pressure, expands the membrane before a new cortex assembles underneath it.

A two-dimensional culture surface offers a broad basal contact area and little geometrical obstruction above the cell. A three-dimensional environment adds pore size, fibre orientation, matrix stiffness, and resistance from surrounding cells. The same cells may switch between elongated, strongly adhesive migration and more rounded, weakly adhesive movement. Proteolysis can enlarge a path through the extracellular matrix, but a sufficiently permissive existing pore need not require digestion. The relatively stiff cell nucleus can become the main bottleneck; its passage depends on deformation, confinement and force transmission. Extensive squeezing can damage the nuclear envelope, so migration speed alone is not a sufficient measure of successful transit.

A decisive experiment removed all functional integrins from mouse leukocytes. Their interstitial migration in three-dimensional environments persisted, and myosin became particularly important for passage through narrow gaps. This distinguishes force generation from a particular adhesion mechanism: confinement and friction can provide useful coupling even without integrin anchoring.^[ref]

Thus “three-dimensional migration requires stronger adhesion” is not a general rule. A useful comparison holds ligand density, matrix stiffness and pore geometry as independently controlled as possible, measures whole-cell and nuclear movement, and perturbs actin, myosin, integrins and matrix digestion separately. Differences then identify which mechanical requirement has changed, rather than treating dimensionality as a single unexplained variable.

External chemical signals can guide cell migration, but the statement is too strong if “determined” means that they uniquely specify whether, how fast and in which direction a cell moves. A chemoattractant gradient biases a cell's internal polarity machinery; it does not directly supply the mechanical work of locomotion. Chemotaxis is directional bias, whereas a change in speed or persistence without directional preference is chemokinesis.

A chemical response depends on receptor abundance, signalling adaptation and the cell's existing cell polarity. The same external field can therefore yield different trajectories in different cell states. Uniform stimulation can increase motility without providing a direction, and spontaneous fluctuations of the actin system can initiate movement without a spatial chemical instruction. Persistent migration combines feedback within the cell with a cue that biases that feedback.

Mechanical and geometrical inputs also matter. Durotaxis describes a bias associated with substrate stiffness, while haptotaxis follows spatial variation in adhesive ligands. Contact guidance by fibre alignment can channel motion even when soluble signals are uniform. Narrow spaces constrain the available paths and can force a switch of protrusive mechanism. These effects are not wholly separate from chemistry: cells sense mechanical forces through molecular interactions. Nevertheless, their directional information resides in mechanics or geometry, not necessarily in an imposed soluble concentration gradient.

Contacts between cells supply another source of organization. Experiments on neural crest cells showed that collisions can cause protrusion collapse and repolarization, and that perturbing noncanonical Wnt signalling disrupts this behaviour and group directionality.^[ref] Contact inhibition of locomotion therefore helps generate collective trajectories through local interactions, rather than each cell independently reading a complete external chemical map. Cohesion and other attractive interactions can prevent such repulsion from simply dispersing the group.

A discriminating experiment independently varies soluble gradient, adhesive pattern and mechanical confinement. Measure direction, speed and persistence separately; reverse the gradient, remove it, and then block the relevant receptor while checking viability and the ability to move. If a directional bias follows the reversed chemical field, that supports chemical guidance. If speed rises under uniform stimulation, that supports chemokinesis. If trajectories remain aligned with fibres after chemical reversal, physical guidance is influential. Manipulating intracellular polarity can test whether a cue is instructive or merely permissive.

The useful conclusion is that motion emerges from an internally powered, state-dependent cell interacting with chemical, mechanical and cellular surroundings. External chemical signals are often decisive inputs, but the trajectory is a property of the coupled system.

Signal transduction initiated by Wnt-family ligands. Distinct pathway branches regulate gene expression, cell polarity and cell behaviour; their effects depend on developmental context.